173 related articles for article (PubMed ID: 8137962)
1. The hypothalamic-pituitary-ovarian axis in patients with endometriosis is suppressed by leuprolide acetate but not by danazol.
Sakata M; Ohtsuka S; Kurachi H; Miyake A; Terakawa N; Tanizawa O
Fertil Steril; 1994 Mar; 61(3):432-7. PubMed ID: 8137962
[TBL] [Abstract][Full Text] [Related]
2. A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis.
Chang SP; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):431-7. PubMed ID: 8803306
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones.
Hickok LR; Burry KA; Cohen NL; Moore DE; Dahl KD; Soules MR
Fertil Steril; 1991 Oct; 56(4):622-7. PubMed ID: 1833245
[TBL] [Abstract][Full Text] [Related]
4. A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis.
Tummon IS; Pepping ME; Binor Z; Radwanska E; Dmowski WP
Fertil Steril; 1989 Mar; 51(3):390-4. PubMed ID: 2522062
[TBL] [Abstract][Full Text] [Related]
5. The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
Maouris P; Dowsett M; Rose G; Edmonds DK; Rothwell C; Robertson WR
Clin Endocrinol (Oxf); 1990 Oct; 33(4):539-46. PubMed ID: 2146047
[TBL] [Abstract][Full Text] [Related]
6. [Studies on endocrine therapy of endometriosis].
Terakawa N
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Aug; 41(8):981-9; discussion 1000-7. PubMed ID: 2530291
[TBL] [Abstract][Full Text] [Related]
7. Sequential danazol/leuprolide acetate therapy for ovarian suppression in an in vitro fertilization patient unresponsive to leuprolide acetate.
Balasch J; Fábregues F; Creus M; Vanrell JA
Gynecol Endocrinol; 1997 Feb; 11(1):21-4. PubMed ID: 9086335
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of endometriosis with synthetic steroids].
Mettler L
Ann Endocrinol (Paris); 1979; 40(3 Suppl):321-9. PubMed ID: 386915
[No Abstract] [Full Text] [Related]
9. Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin.
Dawood MY; Ramos J; Khan-Dawood FS
Fertil Steril; 1995 Jun; 63(6):1177-83. PubMed ID: 7750585
[TBL] [Abstract][Full Text] [Related]
10. Effects of aging on the hypothalamic-hypophyseal-gonadal axis in female rats.
McPherson JC; Costoff A; Mahesh VB
Fertil Steril; 1977 Dec; 28(12):1365-70. PubMed ID: 201506
[TBL] [Abstract][Full Text] [Related]
11. Sex steroid levels during treatment of endometriosis.
Hirschowitz JS; Soler NG; Wortsman J
Obstet Gynecol; 1979 Oct; 54(4):448-50. PubMed ID: 492624
[TBL] [Abstract][Full Text] [Related]
12. Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis.
Sakata M; Terakawa N; Mizutani T; Tanizawa O; Matsumoto K; Terada N; Sudo K
Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1679-84. PubMed ID: 2122726
[TBL] [Abstract][Full Text] [Related]
13. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users.
Hemrika DJ; Slaats EH; Schoemaker J
Am J Obstet Gynecol; 1994 Feb; 170(2):462-8. PubMed ID: 8116698
[TBL] [Abstract][Full Text] [Related]
14. Studies on GnRH agonist suppression of estrogen production in patients with endometriosis.
Ohtsuka S; Terakawa N; Shimizu I; Sakata M; Mizutani T; Miyake A; Tanizawa O; Aono T
Endocrinol Jpn; 1989 Aug; 36(4):611-9. PubMed ID: 2510993
[TBL] [Abstract][Full Text] [Related]
15. Danazol inhibits steroidogenesis by the human ovary in vivo.
Steingold KA; Lu JK; Judd HL; Meldrum DR
Fertil Steril; 1986 May; 45(5):649-54. PubMed ID: 3084301
[TBL] [Abstract][Full Text] [Related]
16. The effect of danazol on pulsatile gonadotropin secretion in women with endometriosis.
Maouris P; Dowsett M; Edmonds DK; Sullivan D
Fertil Steril; 1991 May; 55(5):890-4. PubMed ID: 1902419
[TBL] [Abstract][Full Text] [Related]
17. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis.
Rannevik G
Postgrad Med J; 1979; 55 Suppl 5():14-20. PubMed ID: 537948
[TBL] [Abstract][Full Text] [Related]
18. [The hormonal effect of danazol in women with regular menstrual cycles and in those with ovarian deficiency].
Bertaglia MG; Miragoli A; Dorato F; Nencioni T
Ann Ostet Ginecol Med Perinat; 1980; 101(3):173-80. PubMed ID: 6779692
[No Abstract] [Full Text] [Related]
19. Aberrant estradiol flare despite gonadotropin-releasing hormone-agonist-induced suppression is associated with impaired implantation.
Penzias AS; Lee G; Seifer DB; Shamma FN; DeCherney AH; Reindollar RH; Jones EE
Fertil Steril; 1994 Mar; 61(3):558-60. PubMed ID: 8137986
[TBL] [Abstract][Full Text] [Related]
20. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
